-
[1] Fujitani S., Sun H., Victor L., Pneumonia due to Pseudomonas aeruginosa, CHEST, 2011, 139(4), 909-919
-
[2] Fu W., Demei Z., Fupin H., et al., 2012 CHINET surveillance of bacterial resistance in China, Chinese Journal of Infection and Chemotherapy, 2013, 13(5), 321-330
-
[3] Hongbing C., Chunjiang Z., Hui W., et al., The common pathogens resistance analysis of nosocomial infections in 13 teaching hospitals in china in 2011, Chinese Journal of Internal Medicine, 2013, 52(3), 203-212
-
RELATION NAME
-
[5] Demei Z., Fu W., Fupin H., et al., 2010 CHINET surveillance of bacterial resistance in China, Chinese Journal of Infection and Chemotherapy, 2011, 11(5), 321-329
-
[6] Robert A., Bonomo R.A., Szabo D., Mechanisms of multidrug resistance in Acinetobacter Species and Pseudomonas aeruginosa, Clin. Infect. Dis., 2006, 43, (2), S49-56
-
[7] Ning F.G., Zhao X.Z., Bian J., et al., Large-area burns with pandrug- resistant Pseudomonas aeruginosa infection and respiratory failure, Chin. Med. J. (Engl)., 2011, 124(3), 359-363
-
[8] Chen X., Jin Y., Tang G., New pharmacology, Beijing, People’s Health Publishing House, 2011, 95-107
-
[9] Li H., Li H.P., The mechanism study progress for the macrolide drug treatment of diffuse pan-bronchiolitis, Journal of Clinical Internal Medicine, 2011, 28(7), 500-502